• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《侵袭性肺炎球菌病后低风险成人免疫功能低下状况的筛查：早期发现多发性骨髓瘤的契机》一文的更正

Correction to: Searching for Immunocompromising Conditions in Low-risk Adults After Invasive Pneumococcal Disease: An Opportunity to Uncover Multiple Myeloma Early.

出版信息

Open Forum Infect Dis. 2024 Dec 17;11(12):ofae731. doi: 10.1093/ofid/ofae731. eCollection 2024 Dec.

DOI:10.1093/ofid/ofae731
PMID:39691291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11651153/
Abstract

[This corrects the article DOI: 10.1093/ofid/ofae653.].

摘要

[本文更正了文章的数字对象标识符：10.1093/ofid/ofae653。]

相似文献

1
Correction to: Searching for Immunocompromising Conditions in Low-risk Adults After Invasive Pneumococcal Disease: An Opportunity to Uncover Multiple Myeloma Early.对《侵袭性肺炎球菌病后低风险成人免疫功能低下状况的筛查：早期发现多发性骨髓瘤的契机》一文的更正
Open Forum Infect Dis. 2024 Dec 17;11(12):ofae731. doi: 10.1093/ofid/ofae731. eCollection 2024 Dec.
2
Searching for Immunocompromising Conditions in Low-risk Adults After Invasive Pneumococcal Disease: An Opportunity to Uncover Multiple Myeloma Early.侵袭性肺炎球菌病后低风险成人免疫功能低下状况的筛查：早期发现多发性骨髓瘤的契机
Open Forum Infect Dis. 2024 Nov 8;11(11):ofae653. doi: 10.1093/ofid/ofae653. eCollection 2024 Nov.
3
Correction.更正。
Open Forum Infect Dis. 2024 May 10;11(5):ofae247. doi: 10.1093/ofid/ofae247. eCollection 2024 May.
4
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy.将老年归类为肺炎球菌疫苗政策的高风险、免疫功能低下状态的流行病学和生物学基础。
Expert Rev Vaccines. 2021 Jun;20(6):691-705. doi: 10.1080/14760584.2021.1921579. Epub 2021 Jul 8.
5
Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.免疫功能低下成人患者中，接种 13 价肺炎球菌结合疫苗替代 23 价肺炎球菌多糖疫苗的成本效益分析。
Vaccine. 2013 Dec 5;31(50):6011-21. doi: 10.1016/j.vaccine.2013.10.024. Epub 2013 Oct 19.
6
Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases: an observational database study.美国 19-64 岁患有慢性或免疫功能低下疾病的成年人中肺炎球菌疾病的临床和经济负担：一项观察性数据库研究。
BMC Infect Dis. 2018 Aug 29;18(1):436. doi: 10.1186/s12879-018-3326-z.
7
Correction to: Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials.对《老年人中高价肺炎球菌结合疫苗与13价肺炎球菌结合疫苗的免疫原性和安全性：随机对照试验的系统评价和荟萃分析》的勘误
Open Forum Infect Dis. 2025 Mar 20;12(3):ofaf169. doi: 10.1093/ofid/ofaf169. eCollection 2025 Mar.
8
Correction.更正。
Open Forum Infect Dis. 2023 Oct 6;10(10):ofad489. doi: 10.1093/ofid/ofad489. eCollection 2023 Oct.
9
Correction to: The Complex Landscape of Updated Pneumococcal Conjugate Vaccines.对《更新的肺炎球菌结合疫苗的复杂格局》的更正
Open Forum Infect Dis. 2025 May 7;12(5):ofaf265. doi: 10.1093/ofid/ofaf265. eCollection 2025 May.
10
Risk of Pneumococcal Disease in US Adults by Age and Risk Profile.按年龄和风险特征划分的美国成年人肺炎球菌疾病风险
Open Forum Infect Dis. 2023 Apr 12;10(5):ofad192. doi: 10.1093/ofid/ofad192. eCollection 2023 May.